about
ADHD drugs and serious cardiovascular events in children and young adultsADHD medications and risk of serious cardiovascular events in young and middle-aged adults.Systematic review of the relationship between early introduction of solid foods to infants and the development of allergic disease.Trends in otitis media treatment failure and relapse.The influence of types of decision support on physicians' decision making.Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.Patient-centered design of an information management module for a personally controlled health recordIs duct tape occlusion therapy as effective as cryotherapy for the treatment of the common wart?Implementing a systems-oriented morbidity and mortality conference in remote rural Nepal for quality improvement.Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney.Relation between negligent adverse events and the outcomes of medical-malpractice litigation.Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.Health supervision for children with sickle cell diseaseBenchmarking and quality improvement: the Harvard Emergency Department Quality StudyPediatricians' screening urinalysis practicesPediatricians' clinical decision making: results of 2 randomized controlled trials of test performance characteristics
P50
Q22250876-15DC9501-DC10-4EBA-A737-523D98A3D485Q22253017-C66F495D-9C7E-4FC3-BAC5-05EB808765A5Q33241680-74EB2964-63D7-45A3-8083-105DDF9298E9Q33326520-7F5EDB05-CC1C-48BA-9F8F-03B4737C11A0Q33398465-1AC0F227-B142-4ECF-B50B-0E28ADFFA783Q33611340-07A33EEF-F000-4F1D-B412-3971167E3464Q33678534-A50ACCD9-9005-428F-B4FE-3D627662A42CQ34152844-D0F9E1B3-A005-4FA1-849A-60507EF6F827Q35585107-46E8C449-9E0D-49AA-A2CF-6155227C6635Q37598530-0856F33C-8CDB-4090-B8FE-85F0D48BA8BBQ41264123-12FF5D68-04C7-4841-B523-CE3AB40F79FDQ51105942-307F071A-B027-4703-9D56-4E957330EE82Q73067979-6D9BC4D0-5245-4697-B056-6ABBF21A53C0Q73199797-2074C9E1-EC61-4182-8B78-8D34F76C6476Q81257917-9CBB070E-83D3-4AA2-A977-2F16D2F57A54Q83228800-01334F42-F8E0-4B52-8CD3-2ED4103ADEFD
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Colin M Sox
@ast
Colin M Sox
@en
Colin M Sox
@es
Colin M Sox
@nl
Colin M Sox
@sl
type
label
Colin M Sox
@ast
Colin M Sox
@en
Colin M Sox
@es
Colin M Sox
@nl
Colin M Sox
@sl
prefLabel
Colin M Sox
@ast
Colin M Sox
@en
Colin M Sox
@es
Colin M Sox
@nl
Colin M Sox
@sl
P106
P21
P31
P496
0000-0002-0249-9656